These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

951 related articles for article (PubMed ID: 19237882)

  • 1. Interaction of vasopressin infusion, corticosteroid treatment, and mortality of septic shock.
    Russell JA; Walley KR; Gordon AC; Cooper DJ; Hébert PC; Singer J; Holmes CL; Mehta S; Granton JT; Storms MM; Cook DJ; Presneill JJ;
    Crit Care Med; 2009 Mar; 37(3):811-8. PubMed ID: 19237882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cortisol levels and corticosteroid administration fail to predict mortality in critical illness: the confounding effects of organ dysfunction and sex.
    Rady MY; Johnson DJ; Patel B; Larson J; Helmers R
    Arch Surg; 2005 Jul; 140(7):661-8; discussion 669. PubMed ID: 16027331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The current management of septic shock.
    Russel JA
    Minerva Med; 2008 Oct; 99(5):431-58. PubMed ID: 18971911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of corticosteroids on arginine vasopressin-containing vasopressor therapy for septic shock: a case control study.
    Bauer SR; Lam SW; Cha SS; Oyen LJ
    J Crit Care; 2008 Dec; 23(4):500-6. PubMed ID: 19056013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of continuous vasopressin infusion in patients with septic shock.
    Obritsch MD; Jung R; Fish DN; MacLaren R
    Ann Pharmacother; 2004; 38(7-8):1117-22. PubMed ID: 15178740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular effects of the nitric oxide synthase inhibitor NG-methyl-L-arginine hydrochloride (546C88) in patients with septic shock: results of a randomized, double-blind, placebo-controlled multicenter study (study no. 144-002).
    Watson D; Grover R; Anzueto A; Lorente J; Smithies M; Bellomo R; Guntupalli K; Grossman S; Donaldson J; Le Gall JR;
    Crit Care Med; 2004 Jan; 32(1):13-20. PubMed ID: 14707555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The effect of low-dose hydrocortisone on requirement of norepinephrine and lactate clearance in patients with refractory septic shock].
    Hu B; Li JG; Liang H; Zhou Q; Yu Z; Li L; Luo Y; Liu C; Gan Q
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2009 Sep; 21(9):529-31. PubMed ID: 19751560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vasopressin versus norepinephrine infusion in patients with septic shock.
    Russell JA; Walley KR; Singer J; Gordon AC; Hébert PC; Cooper DJ; Holmes CL; Mehta S; Granton JT; Storms MM; Cook DJ; Presneill JJ; Ayers D;
    N Engl J Med; 2008 Feb; 358(9):877-87. PubMed ID: 18305265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-dose vasopressin is not superior to norepinephrine in septic shock.
    Klinzing S; Simon M; Reinhart K; Bredle DL; Meier-Hellmann A
    Crit Care Med; 2003 Nov; 31(11):2646-50. PubMed ID: 14605537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized, double-blind, placebo-controlled trial of granulocyte colony-stimulating factor in patients with septic shock.
    Stephens DP; Thomas JH; Higgins A; Bailey M; Anstey NM; Currie BJ; Cheng AC
    Crit Care Med; 2008 Feb; 36(2):448-54. PubMed ID: 18216600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arginine vasopressin for the treatment of septic shock in adults.
    Bauer SR; Lam SW
    Pharmacotherapy; 2010 Oct; 30(10):1057-71. PubMed ID: 20874043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Early Vasopressin vs Norepinephrine on Kidney Failure in Patients With Septic Shock: The VANISH Randomized Clinical Trial.
    Gordon AC; Mason AJ; Thirunavukkarasu N; Perkins GD; Cecconi M; Cepkova M; Pogson DG; Aya HD; Anjum A; Frazier GJ; Santhakumaran S; Ashby D; Brett SJ;
    JAMA; 2016 Aug; 316(5):509-18. PubMed ID: 27483065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vasopressin and its immune effects in septic shock.
    Russell JA; Walley KR
    J Innate Immun; 2010; 2(5):446-60. PubMed ID: 20606409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relative adrenal insufficiency as a predictor of disease severity, mortality, and beneficial effects of corticosteroid treatment in septic shock.
    de Jong MF; Beishuizen A; Spijkstra JJ; Groeneveld AB
    Crit Care Med; 2007 Aug; 35(8):1896-903. PubMed ID: 17568326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Administration of the nitric oxide synthase inhibitor NG-methyl-L-arginine hydrochloride (546C88) by intravenous infusion for up to 72 hours can promote the resolution of shock in patients with severe sepsis: results of a randomized, double-blind, placebo-controlled multicenter study (study no. 144-002).
    Bakker J; Grover R; McLuckie A; Holzapfel L; Andersson J; Lodato R; Watson D; Grossman S; Donaldson J; Takala J;
    Crit Care Med; 2004 Jan; 32(1):1-12. PubMed ID: 14707554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. External Corroboration That Corticosteroids May Be Harmful to Septic Shock Endotype A Patients.
    Wong HR; Hart KW; Lindsell CJ; Sweeney TE
    Crit Care Med; 2021 Jan; 49(1):e98-e101. PubMed ID: 33156120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A clinical study of pituitrin versus norepinephrine in the treatment of patients with septic shock].
    Han XD; Sun H; Huang XY; Zhang SY; Wang YD; Ren K; Li F
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2012 Jan; 24(1):33-7. PubMed ID: 22248749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of systemic and renal effects of dopexamine and dopamine in norepinephrine-treated septic shock.
    Schmoelz M; Schelling G; Dunker M; Irlbeck M
    J Cardiothorac Vasc Anesth; 2006 Apr; 20(2):173-8. PubMed ID: 16616656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vasopressin, epinephrine, and corticosteroids for in-hospital cardiac arrest.
    Mentzelopoulos SD; Zakynthinos SG; Tzoufi M; Katsios N; Papastylianou A; Gkisioti S; Stathopoulos A; Kollintza A; Stamataki E; Roussos C
    Arch Intern Med; 2009 Jan; 169(1):15-24. PubMed ID: 19139319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of vasopressor agent in septic shock mortality. Results from the Portuguese Community-Acquired Sepsis Study (SACiUCI study).
    Póvoa PR; Carneiro AH; Ribeiro OS; Pereira AC;
    Crit Care Med; 2009 Feb; 37(2):410-6. PubMed ID: 19114885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 48.